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Abstract 
Strictureplasty for obstructive Crohn’s disease is still controversial because 
lesions are left in place and the suture is performed on a diseased bowel. Many 
surgeons prefer to perform bowel resection, hoping less complication and a lower 
recurrence rate. In this paper, the authors report their strictureplasty experience. 
They performed a systematic retrospective review of the patients suffering from 
Crohn's disease who underwent strictureplasties in a 10-year period in the 
abdominal surgery department of the University Hospital of Liège Sart Tilman, and 
studied the short- and long-term clinical results of 68 strictureplasties performed in 
18 patients. Median follow-up was 63 months (range 12 to 144). Mortality was 0% 
and septic morbidity was 11% (one wound abscess and one leakage). Among the 16 
patients available for the latest follow-up, symptomatic stenotic recurrence had to be 
medically treated in hospital for 4 patients (25%) with a recurrence delay range 19 to 
49 months. Stenosis recurrence needed re-intervention in one patient 48 months after 
surgery: stenosis occurred at distance of the corrected site. These results confirmed 
that strictureplasty is a safe and efficient procedure in selected patients undergoing 
surgery for obstructive Crohn’s disease. 
 




In the beginning of the surgical treatment of Crohn’s disease (1930’s), radical 
resections were considered to be curative. However, mortality and morbidity 
associated to resection was high (1). Progressively, conservative surgery was 
preferred to resection. Because of the technical difficulties linked to inflammatory 
tissues and the high mortality rates of resection, surgeons performed bypasses, 
anastomosing proximal normal ileum to distal normal transverse colon. In the 70’s, 
surgeons went back to resection because of the high complication rates of bypasses, 
as recurrence, infection, blind loop syndrome, and carcinoma (2). In 1961, Brooke et 
al. proposed another conservative treatment, consisting in dividing a stricture 
longitudinally and sewing it transversally (3). This technique was comparable to 
Heineke-Mickulicz pyloroplasty. In India, surgeons encouraged this strictureplasty 
technique by using it on tuberculous enteric strictures (4). 
Strictureplasty may avoid bowel resection and the risk of small bowel 
syndrome (5). Nowadays, many authors have used strictureplasty for short stenotic 
Crohn’s disease without increased fistula or abscess rate. However, the short- and 
long-term effectiveness of strictureplasty for small bowel stenosis in Crohn’s disease 
has not been fully documented. There are still many controversies concerning septic 
complications and recurrence rates of strictureplasties in Crohn's disease. 
In this paper, the authors retrospectively reviewed their experience of 68 
strictureplasties performed in 18 patients suffering from Crohn's disease. They 
assessed their short-term outcome, such as relief of obstructive symptoms and septic 
complications, and also reported long-term clinical follow-up. 
Material and Methods 
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The authors performed a retrospective analysis of a consecutive series of 18 
patients (10 males, 8 females, mean age 42 years) who underwent strictureplasties 
between January 1988 and June 1999 for small bowel Crohn’s disease in the 
abdominal surgery department of the University Hospital of Liège Sart Tilman. 
Detailed informations about prior medical or surgical therapy, initial symptoms, and 
results of physical examination were carefully recorded from the medical charts. The 
diagnosis of Crohn’s disease was confirmed in each case using clinical, radiological 
and histopathological criteria. The mean evolution duration of Crohn's disease prior 
to strictureplasty was 12 years (range: 1 to 27 years). Eleven patients had past history 
of previous abdominal surgery, mainly bowel resection, but two patients had 
previous strictureplasties. The main indication for operation was small bowel 
occlusion unresponsive to medical treatment. Six patients had spread enteritis 
(jejunum and ileum), 4 had ileitis alone, and 8 had combined ileitis and colitis. 
The surgical technique of strictureplasty was similar to Heineke-Mikulicz 
pyloroplasty. Strictures were identified during laparotomy by inspection, palpation 
and sometimes bowel calibration with a Folley probe. A hand-sewn strictureplasty 
with continuous absorbable suture was performed in all cases. If abscess or fistula 
was demonstrated, or if stricture length was superior to 10 cm, resection was 
preferred. The number of strictureplasties, the need for concomitant bowel resection 
and the length of resected bowel were retrieved from the operative report.  
The 6 months follow-up was available for all patients. Perioperative 
complications and their management were analysed from the hospital charts. Long-
term follow-up was conducted by clinical examination or paraclinical exams 
necessary to their regular Crohn's disease follow-up in most patients. Two patients 
were lost to long term follow-up. The latest data were obtained by phone interview. 
This interview provided information about recurrent symptoms, weight change, 
 5 
alteration in medical treatment, and any subsequent hospitalisation or surgical 
procedures after strictureplasty. Median consultation or clinical follow-up was 53 
months (range 10 to 143); the follow-up by phone was 63 months (12-144). 
Results 
In the study period, 68 strictureplasties were performed in 18 patients. The 
median hospital stay was 14 days (range 7 to 39 days). Among the 18 patients, 15 
(83%) underwent synchronous resection procedure at the time of strictureplasty (11 
small bowel resections, and/or 6 ileo-colic resection). The length of resected bowel 
was recorded for 17 patients. The total length of bowel resection, including addition 
of length of previous surgical resections, was 73.9 +/- 36.7 cm. There was no 
perioperative death. Strictureplasty related septic morbidity was observed in 2 
patients (one peritonitis due to leakage of a strictureplasty, and one wound abscess). 
A prolonged ileus was observed in one patient. The anastomotic leakage needed a 
reoperation at day 3 and benefited from an ileostomy and peritoneal rinsing. 
Ileostomy was closed 3 months later. 
Immediately after the surgical procedure, 88% patients noted relief of 
obstructive symptoms. Six months after operation, 9 patient felt a marked 
improvement (50%), a moderated improvement in 3 (16%). Three patients reported 
minimal to unchanged symptomatology, and two patients reported worsening in 
clinical status. An average weight gain of 4.88kg (range 0 to 10) was reported in 
patients 6 months after strictureplasty. 
Among the 16 patients available for the latest follow-up, symptomatic stenotic 
recurrence (intestinal occlusion) had to be medically treated in hospital for 4 patients 
(25%) with a recurrence delay ranging 19 to 49 months. Another patient (6%) 
required reoperation for resurgence of occlusive symptoms 48 months after the first 
operation. The occlusive site was distant from the previous strictureplasty. 
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Discussion 
The principle of strictureplasty is to correct obstructive stricture without 
sacrificing the length of the small bowel. It has become an accepted surgical option in 
the management of obstructive Crohn’s disease of the small bowel (6-9). 
Strictureplasty can only be justified if results prove the procedure to be safe. As 
strictureplasty involves a suture line fashioned through macroscopic disease, there 
are many controversies about a possible increase of septic complication or a greater 
recurrence rate of the disease. However, several studies have demonstrated that 
recurrence of the Crohn’s disease is independent of the presence of disease at the 
intestinal margin (10-11). Also, Crohn’s disease is potentially pan-intestinal, and the 
patient is always at risk of relapse.  
The greatest series on strictureplasty in the literature from the last 15 years 
was summarised on Table 1. Operative mortality rates for resection in Crohn’s 
disease range from 0.3% to 3.2% (12). To date, no operative mortality has been 
reported for strictureplasty. Septic complications after classical resection for Crohn’s 
disease were reported in a range of 3% to 49% (12). After strictureplasty, 
perioperative septic complications may vary from 0% to 10%. It was 11% in our 
series. 
Incidence of recurrence requiring surgery ranged from 0% at 6 months to 28% 
at 60 months (except the study of Yamamoto concerning strictureplasty for stenotic 
resurgence on ileocolic resection: 46% at 90 months (13)). Most reoperations were 
performed for new sites of stenosis. 
In conclusion, strictureplasty is a safe alternative to resection in obstructive 
Crohn’s disease. This technique must be considered in parallel to resection and not in 
replacement of it. Moreover, strictureplasty is not recommended for active disease, or 
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Legends of Table 1 
Table 1: Series of the literature 
